Gedeon Richter Plc., a Hungarian pharma, acquired the 50% of its China JV that it did not already own from its former partner, Rxmidas Pharmaceuticals Holdings. The JV was announced in December 2010, with a $2.4 million capital contribution from Gedeon Richter, and it currently distributes the company's OTC and contraceptive products in China. The financial terms of the agreement were not disclosed.